Incap that has grown exponentially in recent years faces an acid test toward the end of the year, as the volume of the customer that dominates its revenue decreases. We consider the situation to be temporary and expect Incap's strengths, in particular high cost efficiency, to keep the company on a growth path in the longer term. Despite the share’s highish risk level, both in the short and long term, we find Incap's valuation to be low (2024e: P/E 13x, EV/EBIT 7x), so looking beyond the challenges of this year the share’s risk adjusted expected return is sufficient in our opinion.